113 related articles for article (PubMed ID: 8165702)
21. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
22. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
23. Human cytotoxic T lymphocytes. II. Frequency analysis of cyclosporin A-sensitive alloreactive cytotoxic T-lymphocyte precursors.
Kabelitz D; Zanker B; Zanker C; Heeg K; Wagner H
Immunology; 1987 May; 61(1):57-62. PubMed ID: 3108142
[TBL] [Abstract][Full Text] [Related]
24. Cytokine requirements for production of a novel anti-CD8-resistant CTL population.
Lamousé-Smith ES; Dougall DS; McCarthy SA
J Immunol; 1999 Oct; 163(8):4160-7. PubMed ID: 10510351
[TBL] [Abstract][Full Text] [Related]
25. Acute rejection in heart transplant patients is associated with the presence of committed donor-specific cytotoxic lymphocytes in the graft but not in the blood.
Vaessen LM; Baan CC; Ouwehand AJ; Jutte NH; Balk AH; Mochtar B; Claas FH; Weimar W
Clin Exp Immunol; 1992 May; 88(2):213-9. PubMed ID: 1572086
[TBL] [Abstract][Full Text] [Related]
26. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
Roelen DL; van Beelen E; van Bree SP; van Rood JJ; Völker-Dieben HJ; Claas FH
Transplantation; 1995 Apr; 59(7):1039-42. PubMed ID: 7709440
[TBL] [Abstract][Full Text] [Related]
27. The lymphocyte subpopulations in cyclosporine-treated human heart rejection.
Weintraub D; Masek M; Billingham ME
J Heart Transplant; 1985 Feb; 4(2):213-6. PubMed ID: 3916488
[TBL] [Abstract][Full Text] [Related]
28. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
29. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
30. In vivo mechanisms of alloreactivity. VI. Evidence that alloantigen deposition initiates both local and systemic mechanisms that influence CTL accumulation at a graft site.
Orosz CG; Bishop DK; Ferguson RM
Transplantation; 1989 Nov; 48(5):818-24. PubMed ID: 2815254
[TBL] [Abstract][Full Text] [Related]
31. Activation requirements, lytic mechanism, and development of a novel anti-CD8-resistant CTL population.
McCarthy SA; Mainwaring MS; Dougall DS; Lamouse-Smith ES
J Immunol; 1998 Mar; 160(6):2715-24. PubMed ID: 9510171
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
[TBL] [Abstract][Full Text] [Related]
33. Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.
Dijke IE; Korevaar SS; Caliskan K; Balk AH; Maat AP; Weimar W; Baan CC
Transplantation; 2009 Apr; 87(8):1191-200. PubMed ID: 19384166
[TBL] [Abstract][Full Text] [Related]
34. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
[TBL] [Abstract][Full Text] [Related]
35. Rat heterotopic heart transplantation: quantification and analysis of cell mediated cytotoxicity.
Kirby JA; Reader JA; Parfett GJ; Pepper JR
Clin Exp Immunol; 1988 Jan; 71(1):113-9. PubMed ID: 3280177
[TBL] [Abstract][Full Text] [Related]
36. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
[TBL] [Abstract][Full Text] [Related]
37. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
[TBL] [Abstract][Full Text] [Related]
38. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
39. Experimental and clinical allogeneic heart transplant rejection: correlations between histology and immune reactivity detected by cytokine messenger RNA.
Normann SJ; Peck AB; Staples ED; Salomon DR; Mills RM
J Heart Lung Transplant; 1996 Aug; 15(8):778-89. PubMed ID: 8878760
[TBL] [Abstract][Full Text] [Related]
40. Alloreactive T cells that do not require TCR and CD8 coengagement are present in naive mice and contribute to graft rejection.
Smith PA; Potter TA
J Immunol; 1998 Jun; 160(11):5382-9. PubMed ID: 9605138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
